Development of Therapeutic-Grade Small Interfering RNAs by Chemical Engineering

Cites (266)

Items 201–278 of 278

1. Toll‐like receptor (TLR) 3 immune modulation by unformulated small interfering RNA or DNA and the role of CD14 (in TLR‐mediated effects)
   Cordula Weber, Christian Müller, Anja Podszuweit, Carmen Montino, Jörg Vollmer, Alexandra Forsbach · 2012 · Immunology
2. A Status Update of Modified Oligonucleotides for Chemotherapeutics Applications
   Yogesh S. Sanghvi · 2011 · Current Protocols in Nucleic Acid Chemistry
3. High doses of siRNAs induce eri-1 and adar-1 gene expression and reduce the efficiency of RNA interference in the mouse
   Jie Hong, Zhikang Qian, Shuiyuan Shen, Taishan Min, Chang Tan, Jianfeng Xu, Yingchun Zhao, Weida Huang · 2005 · Biochemical Journal
4. Integrated Magnetic Bionanocomposites through Nanoparticle-Mediated Assembly of Ferritin
   Sudhanshu Srivastava, Bappaditya Samanta, Brian J. Jordan · 2007 · Journal of the American Chemical Society
5. Gene Silencing Activity of siRNA Molecules Containing Phosphorodithioate Substitutions
   Xianbin Yang, Małgorzata Sierant, Magdalena Janicka, Łukasz Pęczek, Carlos Martinez, Tom Hassell, Na Li, Xin Li, Tianzhi Wang, Barbara Nawrot · 2012 · ACS Chemical Biology
6. LNA (LOCKED NUCLEIC ACID) AND THE DIASTEREOISOMERIC α-L-LNA: CONFORMATIONAL TUNING AND HIGH-AFFINITY RECOGNITION OF DNA/RNA TARGETS
   Jesper Wengel, Michael Åxman Petersen, Kathrine E. Nielsen, Gitte A. Jensen, Anders E. Håkansson, Ravindra Kumar, Mads D. Sørensen, Vivek K. Rajwanshi, Torsten Bryld, Jens Peter Jacobsen · 2001 · Nucleosides Nucleotides & Nucleic Acids
7. Biochemical properties of phosphonoacetate and thiophosphonoacetate oligodeoxyribonucleotides
   David M. Sheehan · 2003 · Nucleic Acids Research
8. The siRNA sequence and guide strand overhangs are determinants of in vivo duration of silencing
   Walter R. Strapps, Victoria Pickering, Gladys T. Muiru, Julie Rice, Stacey Orsborn, Barry A. Polisky, Alan B. Sachs, Steven R. Bartz · 2010 · Nucleic Acids Research
9. TLR3-mediated NF-κB signaling in human esophageal epithelial cells
   Diana M. Lim, Sneha Narasimhan, Carmen Z. Michaylira, Mei‐Lun Wang · 2009 · American Journal of Physiology-Gastrointestinal and Liver Physiology
10. Small Interfering RNAs Induce Target-Independent Inhibition of Tumor Growth and Vasculature Remodeling in a Mouse Model of Hepatocellular Carcinoma
    Mathieu Bergé, Philippe Bonnin, Eric Sulpice, José Vilar, David Allanic, Jean‐Sébastien Silvestre, Bernard I Levy, Gordon C. Tucker, Gérard Tobelem, Tatyana Merkulova‐Rainon · 2010 · American Journal Of Pathology
11. In Situ Analysis of Single-Stranded and Duplex siRNA Integrity in Living Cells
    Koen Raemdonck, Katrien Remaut, Bart Lucas, Niek N. Sanders, Jo Demeester, Stefaan C. De Smedt · 2006 · Biochemistry
12. Chemically Modified Short Interfering Hybrids (siHYBRIDS): Nanoimmunoliposome DeliveryIn VitroandIn Vivofor RNAi of HER-2
    Richard I. Hogrefe, Alexandre V. Lebedev, Gerald Zon, Kathleen F. Pirollo, Antonina S. Rait, Qi Zhou, Wei Yu, Esther H. Chang · 2006 · Nucleosides Nucleotides & Nucleic Acids
13. Synthesis of 2′-O-modified adenosine building blocks and application for RNA interference
    Dalibor Odadzic, Jesper B. Bramsen, Romualdas Smičius, Claus Bus, Jørgen Kjems, Joachim W. Engels · 2007 · Bioorganic & Medicinal Chemistry
14. Synthesis, Structure, and Biological Activity of Dumbbell-Shaped Nanocircular RNAs for RNA Interference
    Naoko Abe, Hiroshi Abe, Chisato Nagai, Mitsuru Harada, Hiroto Hatakeyama, Hideyoshi Harashima, Takahito Ohshiro, Mizuki Nishihara, Kazuhiro Furukawa, Mizuo Maeda et al. · 2011 · Bioconjugate Chemistry
15. Intracellular stability of 2′-OMe-4′-thioribonucleoside modified siRNA leads to long-term RNAi effect
    Mayumi M. Takahashi, Chisato Nagai, Hiroto Hatakeyama, Noriaki Minakawa, Hideyoshi Harashima, Akira Matsuda · 2012 · Nucleic Acids Research
16. Study of Modification Pattern–RNAi Activity Relationships by Using siRNAs Modified with 4′‐Thioribonucleosides
    Shuichi Hoshika, Noriaki Minakawa, Aki Shionoya, Keiko Imada, Naoki Ogawa, Akira Matsuda · 2007 · ChemBioChem
17. Naked siLNA-Mediated Gene Silencing of Lung Bronchoepithelium EGFP Expression After Intravenous Administration
    Sys Zoffmann Glud, Jesper B. Bramsen, Frederik Dagnæs‐Hansen, Jesper Wengel, Kenneth Alan Howard, Jens Randel Nyengaard, Jørgen Kjems · 2009 · Oligonucleotides
18. RNAse A‐like enzymes in serum inhibit the anti‐neoplastic activity of siRNA targeting polo‐like kinase 1
    Jörg Haupenthal, Christina Baehr, Stefan Zeuzem, Albrecht Piiper · 2007 · International Journal of Cancer
19. Determinants of Cytokine Induction by Small Interfering RNA in Human Peripheral Blood Mononuclear Cells
    Maryam Zamanian-Daryoush, João Trindade Marques, Michael Paul Gantier, Mark A. Behlke, Matthias John, Patricia A. Rayman, James Harold Finke, Bryan R.G. Williams · 2008 · Journal of Interferon & Cytokine Research
20. Comprehensive analysis of sequence-specific stability of siRNA
    Junmei Hong, Yuanyu Huang, Jun Li, Yi Fan, Jie Zheng, Huang Huang, Na Wei, Yongqiang Shan, Mingrui An, Hongyan Zhang et al. · 2010 · The FASEB Journal
21. RNA-based therapies
    Irena Melnikova · 2007 · Nature Reviews Drug Discovery
22. Structural Characterization and Biological Evaluation of Small Interfering RNAs Containing Cyclohexenyl Nucleosides
    Koen Nauwelaerts, Michael Fisher, Matheus Froeyen, Eveline Lescrinier, Arthur A. Van Aerschot, Xu D, Robert K. DeLong, Hyumin Kang, Rudolph L. Juliano, Piet A. Herdewijn · 2007 · Journal of the American Chemical Society
23. Synthesis, Gene Silencing, and Molecular Modeling Studies of 4′-C-Aminomethyl-2′-O-methyl Modified Small Interfering RNAs
    Kiran R. Gore, Ganesh N. Nawale, S. Harikrishna, Vinita G. Chittoor-Vinod, Sushil Kumar Pandey, Claudia Höbartner, Swati Patankar, Pushpangadan Indira Pradeepkumar · 2012 · The Journal of Organic Chemistry
24. Atelocollagen-mediated Systemic Delivery Prevents Immunostimulatory Adverse Effects of siRNA in Mammals
    Shinichiro Inaba, Shunji Nagahara, Naoki Makita, Yuzo Tarumi, Takuji Ishimoto, Seiichi Matsuo, Kenji Kadomatsu, Yoshifumi Takei · 2011 · Molecular Therapy
25. The effects of thiophosphate substitutions on native siRNA gene silencing
    Zheng-Yin Li, Haibo Mao, Deborah A. Kallick, David G. Gorenstein · 2005 · Biochemical and Biophysical Research Communications
26. Biological effects of hexitol and altritol-modified siRNAs targeting B-Raf
    MICHAEL S. FISHER, Mikhail Abramov, Arthur A. Van Aerschot, Jef Rozenski, Vidula Dixit, Rudy L. Juliano, Piet A. Herdewijn · 2009 · European Journal of Pharmacology
27. Modified siRNA Structure With a Single Nucleotide Bulge Overcomes Conventional siRNA-mediated Off-target Silencing
    Pooja Dua, Jae Wook Yoo, Soyoun Kim, Dong-ki Lee · 2011 · Molecular Therapy
28. Chemically modified siRNA prolonged RNA interference in renal disease
    Yoshitsugu Takabatake, Yoshitaka Isaka, Masayuki Mizui, Hiroshi Kawachi, Shiro Takahara, Enyu Imai · 2007 · Biochemical and Biophysical Research Communications
29. Comprehensive evaluation of canonical versus Dicer-substrate siRNA in vitro and in vivo
    Donald J. Foster, Scott A. Barros, Rick Duncan, Sarfraz Shaikh, William L. Cantley, Amy Dell, Elena Bulgakova, Jonathan O′Shea, Nate Taneja, Satya Kuchimanchi et al. · 2012 · RNA
30. Both Strands of siRNA Have Potential to Guide Posttranscriptional Gene Silencing in Mammalian Cells
    Junxia Wei, Jie Yang, Jifeng Sun, Lintao Jia, Yong Zhang, Huizhong Zhang, Xia Li, Yan–Ling Meng, Li-Bo Yao, Angang Yang · 2009 · PLoS ONE
31. Fully 2′‐Deoxy‐2′‐Fluoro Substituted Nucleic Acids Induce RNA Interference in Mammalian Cell Culture
    Richard Blidner, Robert P. Hammer, Mandi J. Lopez, SANDRA O. ROBINSON, W. Todd Monroe · 2007 · Chemical Biology & Drug Design
32. Erratum: RNA-based therapies
    Irena Melnikova · 2008 · Nature Reviews Drug Discovery
33. Stability of 3′ double nucleotide overhangs that model the 3′ ends of siRNA
    AMANDA S. O’TOOLE, STACY MILLER, Martin J. Serra · 2005 · RNA
34. siRNA binding proteins of microglial cells: PKR is an unanticipated ligand
    Zhiren Zhang, Toni Weinschenk, Ke‐Tai Guo, Hermann J. Schluesener · 2005 · Journal of Cellular Biochemistry
35. Deciphering the Code of Innate Immunity Recognition of siRNAs
    Mouldy Sioud · 2008 · Methods in molecular biology
36. Predicting siRNA potency with random forests and support vector machines
    Liangjiang Wang, Caiyan Huang, Jack Y. Yang · 2010 · BMC Genomics
37. Sequences derived from self-RNA containing certain natural modifications act as suppressors of RNA-mediated inflammatory immune responses
    Sibylle Tluk, Marion Jurk, Alexandra Forsbach, Risini D. Weeratna, Ulrike Samulowitz, ARTHUR M. KRIEG, Stefan Bauer, J. Vollmer · 2009 · International Immunology
38. Synthesis and biological activity of phosphonoacetate- and thiophosphonoacetate-modified 2′-O-methyl oligoribonucleotides
    Richard Threlfall, Adrián Gabriel Torres, Angelika A. Krivenko, Michael John Gait, Marvin H. Caruthers · 2011 · Organic & Biomolecular Chemistry
39. Small Interfering RNAs Induce Macrophage Migration Inhibitory Factor Production and Proliferation in Breast Cancer Cells via a Double-Stranded RNA-Dependent Protein Kinase-Dependent Mechanism
    Michelle E. Armstrong, Michael Paul Gantier, Lili Li, Wen Yuan Chung, Amanda H McCann, John Andrew Baugh, Seamas C. Donnelly · 2008 · The Journal of Immunology
40. Antisense oligonuclotides with oxetane-constrained cytidine enhance heteroduplex stability, and elicit satisfactory RNase H response as well as showing improved resistance to both exo and endonucleasesElectronic supplementary information (ESI) available: RNA cleavage kinetics. See http://www.rsc.org/suppdata/ob/b2/b210163g/
    Pushpangadan Indira Pradeepkumar, Nariman V. Amirkhanov, JYOTI B. CHATTOPADHYAYA · 2002 · Organic & Biomolecular Chemistry
41. Comparing 2-nt 3' overhangs against blunt-ended siRNAs: a systems biology based study
    Preetam Ghosh, Robert Dullea, James E Fischer, Tom Turi, Ronald W. Sarver, Chaoyang Zhang, Kalyan Basu, Sajal Kumar Das, Bradley W. Poland · 2009 · BMC Genomics
42. Solid-Phase Synthesis of Modified RNAs Containing Amide-Linked Oligoribonucleosides at Their 3′-End and Their Application to siRNA
    Reiko Iwase, Takaaki Toyama, Kengo Nishimori · 2007 · Nucleosides Nucleotides & Nucleic Acids
43. Minimizing off-target effects by using diced siRNAs for RNA interference.
    Jason W. Myers, Jen‐Tsan Chi, Delquin Gong, Marci E. Schaner, Patrick O. Brown, James E. Ferrell · 2006 · Europe PMC (PubMed Central)
44. Is RNAi Dead?
    Arthur Μ. Krieg · 2011 · Molecular Therapy
45. Antisense—down, but not out
    Carol Potera · 2007 · Nature Biotechnology
46. Differential repression of human and mouse TERT genes during cell differentiation
    Shuwen Wang, Yuanjun Zhao, Chunguang Hu, Jiyue Zhu · 2009 · Nucleic Acids Research
47. Rb/E2F1 Regulates the Innate Immune Receptor Toll-Like Receptor 3 in Epithelial Cells
    Manabu Taura, Mary Ann Suico, Kosuke Koyama, Kensei Komatsu, Rui Miyakita, Chizuru Matsumoto, Eriko Kudo, Ryusho Kariya, Hiroki Goto, Shunsuke Kitajima et al. · 2012 · Molecular and Cellular Biology
48. Involvement of Activation of PKR in HBx-siRNA-Mediated Innate Immune Effects on HBV Inhibition
    Qiuju Han, Cai Zhang, Jian Zhang, Zhigang Tian · 2011 · PLoS ONE
49. Unique Gene‐Silencing and Structural Properties of 2′‐Fluoro‐Modified siRNAs
    Muthiah Manoharan, Akin Akinc, Rajendra K. Pandey, June Qin, Philipp Hadwiger, Matthias John, Kathy Mills, Klaus Charissé, Martin A. Maier, Lubomir V. Nechev et al. · 2011 · Angewandte Chemie
50. Self-splicing of a group I intron reveals partitioning of native and misfolded RNA populations in yeast
    Scott A. Jackson, Sujatha P. Koduvayur, Sarah A. Woodson · 2006 · RNA
51. RNA interference by 2′,5′-linked nucleic acid duplexes in mammalian cells
    Thazha P. Prakash, Bryan A. Kraynack, Brenda F. Baker, Eric E. Swayze, Balkrishen Bhat · 2006 · Bioorganic & Medicinal Chemistry Letters
52. Functionally Enhanced siRNA Targeting TNFα Attenuates DSS-induced Colitis and TLR-mediated Immunostimulation in Mice
    Sandra M. Ocampo, Carolina Romero, Anna Maria Aviñó, Juan F. Burgueño, Miguel Angel Gassull, Jordi Bermúdez, Ramón Eritja, Ester Fernández, Jose Carlos Perales · 2011 · Molecular Therapy
53. RNAi momentum fizzles as pharma shifts priorities
    Charles Schmidt · 2011 · Nature Biotechnology
54. Approximate Bayesian feature selection on a large meta-dataset offers novel insights on factors that effect siRNA potency
    Jochen W. Klingelhoefer, Loukas Moutsianas, Chris C. Holmes · 2009 · Bioinformatics
55. 2'- O -Methyl–Modified Anti- MDR1 Fork-siRNA Duplexes Exhibiting High Nuclease Resistance and Prolonged Silencing Activity
    Natalya S. Petrova, Mariya I. Meschaninova, Alya G. Venyaminova, Зенкова Марина Аркадьевна, Valentin V. Vlassov, Elena L. Chernolovskaya · 2010 · Oligonucleotides
56. Immunostimulatory Potential of Silencing RNAs Can Be Mediated by a Non-Uridine-Rich Toll-Like Receptor 7 Motif
    Marion Jurk, Ghania Chikh, Bettina Schulte, Andrea Kritzler, Denise Richardt‐Pargmann, Catherine Lampron, Rachel Luu, Arthur Μ. Krieg, Alain P. Vicari, Jörg Vollmer · 2011 · Nucleic Acid Therapeutics
57. The road to therapeutic RNA interference (RNAi): Tackling the 800 pound siRNA delivery gorilla.
    Bryan R. Meade, Steven F. Dowdy · 2009 · PubMed
58. Increased potency and longevity of gene silencing using validated Dicer substrates.
    Eli Hefner, Kay H. Clark, C Whitman, Mark A. Behlke, Scott D. Rose, A. S. Peek, T Rubio · 2008 · PubMed Central
59. Drug giants turn their backs on RNA interference
    Heidi K. Ledford · 2010 · Nature
60. Silencing Gene Expression with Dicer-Generated siRNA Pools
    Jason W. Myers, James E. Ferrell · 2005 · Humana Press eBooks
61. FDA approves fomivirsen, famciclovir, and Thalidomide. Food and Drug Administration.
    Liz Highleyman · 1998 · PubMed
62. Competition Between siRNA Duplexes: Impact of RNA-Induced Silencing Complex Loading Efficiency and Comparison Between Conventional-21 bp and Dicer-Substrate siRNAs
    Marcel Tanudji, Dorothy A. Machalek, Greg M. Arndt, Laurent P. Rivory · 2009 · Oligonucleotides
63. Adenosine Modification May Be Preferred for Reducing siRNA Immune Stimulation
    Raymond V. Fucini, Henry J. Haringsma, Patricia Deng, W. Michael Flanagan, Aarron T. Willingham · 2012 · Nucleic Acid Therapeutics
64. Sequence-specific potent induction of IFN-alpha by short interfering RNA in plasmacytoid dendritic cells through TLR7
    V. Hornung, M. Guenthner-Biller, C. Bourquin, A. Ablasser, M. Schlee, S. Uematsu, A. Noronha, M. Manoharan, Shizuo Akira, A. de Fougerolles et al. · 2005
65. Competition potency of siRNA is specified by the 5′-half sequence of the guide strand
    Jae Wook Yoo, Soyoun Kim, Dong-ki Lee · 2007 · Biochemical and Biophysical Research Communications
66. Immunostimulatory properties and antiviral activity of modified HBV-specific siRNAs
    Duckhyang Shin, Soo In Kim, Mahnhoon Park, Meehyein Kim · 2007 · Biochemical and Biophysical Research Communications
67. Degradation of hammerhead ribozymes by human ribonucleases
    Lirong Qiu, Andre Luis Moreira, Gilla Kaplan, Ruth Levitz, J.-Y. Wang, Chen Xu, Karl Drlica · 1998 · Molecular and General Genetics MGG
68. A systematic analysis of the silencing effects of an active siRNA at all single-nucleotide mismatched target sites
    Qiu Du · 2005 · Nucleic Acids Research
69. Synthesis and Biological Activity of Phosphonocarboxylate DNA
    Christina M. Yamada, Douglas J. Dellinger, Marvin H. Caruthers · 2007 · Nucleosides Nucleotides & Nucleic Acids
70. 21. Efficient In Vivo Delivery of siRNA to Liver by Conjugation of Alpha-Tocopherol
    2008 · Molecular Therapy
71. In vivo screening of modified siRNAs for non-specific antiviral effect in a small fish model: number and localization in the strands are important
    Brian Dall Schyth, Jesper B. Bramsen, Malgorzata Maria Pakula, Sekar Larashati, Jørgen Kjems, Jesper Wengel, Niels Lorenzen · 2012 · Nucleic Acids Research
72. Contributions of 3′-overhang to the dissociation of small interfering RNAs from the PAZ domain: Molecular dynamics simulation study
    Hui Sun Lee, Soo Nam Lee, Chul Hyun Joo, Heuiran Lee, Hansaem Lee, Seung Yong Yoon, Yoo Kyum Kim, Han Choe · 2006 · Journal of Molecular Graphics and Modelling
73. High-Dose siRNAs Upregulate Mouse Eri-1 at both Transcription and Posttranscription Levels
    Yingnan Bian, Wei Lan Zhou, Yingchun Zhao, Xiaoping Li, Wei Geng, Ruixin Hao, Qing Kun Yang, Weida Huang · 2011 · PLoS ONE
74. Stimulation of the XPB ATP-dependent helicase by the beta subunit of TFIIE
    Yin Chun Lin · 2005 · Nucleic Acids Research
75. Structural and Binding Study of Modified siRNAs with the Argonaute 2 PAZ Domain by NMR Spectroscopy
    Mohitosh Maiti, Koen Nauwelaerts, Eveline Lescrinier, Piet A. Herdewijn · 2011 · Chemistry - A European Journal
76. Informatics Approach to the Rational Design of siRNA Libraries
    Jerry Osagie Ebalunode, Charles Jagun, Weifan Zheng · 2010 · Methods in molecular biology
77. RNA interference induced by siRNAs modified with 4′-thioribonucleosides
    Shuichi Hoshika, Noriaki Minakawa, Akira Matsuda · 2005 · Nucleic Acids Symposium Series
78. Immunostimulatory Potential of Silencing RNAs Can Be Mediated by a Non-Uridine-Rich Toll-Like Receptor 7 Motif
    Marion Jurk, Ghania Chikh, Bettina Schulte, Andrea Kritzler, Denise Richardt‐Pargmann, Catherine Lampron, Rachel Luu, Arthur Μ. Krieg, Alain P. Vicari, Jörg Vollmer · 2011 · Oligonucleotides